News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Maite Bourlon: How to treat metastastic urothelial carcinoma after 1st line EV and Pembrolizumab
Maite Bourlon/ascopubs.org
Mar 2, 2025, 14:36

Maite Bourlon: How to treat metastastic urothelial carcinoma after 1st line EV and Pembrolizumab

Maite Bourlon, Associate Professor and Head of the Urologic Oncology Clinic at the National Institute of Medical Sciences and Nutrition Salvador Zubirán, shared a post on X:

“How to treat metastastic urothelial carcinoma after 1st line EV and Pembrolizumab?

  • Lack of evidence and need trials
  • Look at proposed algorithm
  • Ongoing trials mUC after EV and ICIs
  • Table of efficacy outcomes of platinum, erdafitinib (FGFR3) and trastu deruxtecan.”

“Optimizing Treatment Strategies for Advanced Urothelial Cancer: What Comes After Frontline Enfortumab Vedotin and Pembrolizumab?”

Authors: Maria Bourlon, Paola Valdez, Thomas Powles, Thomas Flaig.

Maite Bourlon: How to treat metastastic urothelial carcinoma after 1st line EV and Pembrolizumab

More posts featuring Maite Bourlon.

cancer Enfortumab vedotin Maite Bourlon metastastic urothelial carcinoma OncoDaily Oncology Paola Valdez pembrolizumab Thomas Flaig Thomas Powles
Special Coverage
Insight
Mar 2, 2025, 14:36
Maite Bourlon: How to treat metastastic urothelial carcinoma after 1st line EV and Pembrolizumab
Blog
Mar 2, 2025, 14:21
Chadi Nabhan: Debating Smoldering Myeloma on Healthcare Unfiltered
Science
Mar 2, 2025, 13:57
Mohammad Jad Moussa: Nivolumab plus ipilimumab in metastatic variant histology renal cell carcinoma
Blog
Mar 2, 2025, 13:50
Niyati Shah: Empowering Patients through Advocacy
Blog
Mar 2, 2025, 13:37
Cervical Cancer is Preventable: Education is Key - Medicaid Cancer Foundation
Career
Mar 2, 2025, 13:31
Irbaz Riaz: Honored to be named a Gerstner Scholar in AI Translation at Mayo Clinic
Science
Mar 2, 2025, 13:26
The ALEXANDRA/IMpassion030 trial on Adjuvant Atezolizumab for Early TNBC by Michail Ignatiadis et al.
Blog
Mar 2, 2025, 13:10
Monica Bertagnolli: All who pursue a career in biomedical research care deeply about the ultimate goals of the work
Science
Mar 2, 2025, 13:01
Hagop Youssoufian: Encelimab with or without dostarlimab in advanced/metastatic solid tumors
Insight
Mar 2, 2025, 12:30
Mariana Brandao: Rewarding to see that ALEXANDRA/IMpassion030 trial has been made public to the medical community
Blog
Mar 2, 2025, 12:25
Arevik Stepanyan: Bringing Innovation and Partnerships to Armenian Clinical Research
Blog
Mar 2, 2025, 12:18
Don Dizon: The heart of Global Oncology - striving together for equity for people living with cancer everywhere